January 2025

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel – January 22, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve […]

BioHarvest Announces Appointment of Sharon Malka to Board of Directors Read More »

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Vancouver, British Columbia and Rehovot, Israel – January 8, 2025– BioHarvest Sciences Inc., (Nasdaq: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2024 can be summarized as a year

BioHarvest Issues Shareholder Letter and Provides Corporate Update Read More »